SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Tag: MERITAGE-I

    New Radiation Treatment for Wet AMD

    Posted on February 9, 2012 by droberts
  • February 9, 2012

    New Radiation Treatment for Wet AMD

    by Dan Roberts [It was reported on 2/9/12 that Phase III of this study did not meet it’s primary endpoint at 2 years. The information in this article describes the progress up to that point.] NeoVista, Inc. announced on June 17, 2007 the official commencement of the CABERNET (Cnv secondary to Amd treated with BEta […]

      Also posted in
    • Research and Developments
  • Summary of Research and Developments in Macular Degeneration, 2010-2011

    Posted on June 1, 2011 by droberts
  • June 1, 2011

    Summary of Research and Developments in Macular Degeneration, 2010-2011

    by Dan Roberts June 19, 2011 Introduction Since 2006, I have done my best to condense the high points of the previous year’s macular degeneration research into a single report that is concise and understandable for the layperson. I do so, because I understand first hand how important it is to be aware of everything […]

      Also posted in
    • Research and Developments
  • Brachytherapy May Reduce Burden of Treatment and Further Improve Visual Acuity

    Posted on October 27, 2009August 26, 2020 by droberts
  • October 27, 2009

    Brachytherapy May Reduce Burden of Treatment and Further Improve Visual Acuity

    (Updated August 26, 2020) San Francisco, CA (PRWEB) October 27, 2009 — NeoVista, Inc. made public at the American Academy of Ophthalmology meeting the company’s interim study results from the preliminary study MERITAGE-I. The study was designed to examine the company’s novel epimacular brachytherapy procedure when used in patients that require chronic anti-VEGF treatment for […]

      Also posted in
    • Research and Developments
    • Therapies, Treatments, and Procedures
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.